You are here: Industry Insights > CDMO

News List

Vetter Again Demonstrates Industry Leadership in Sustainability Initiatives PharmaSources
June 15, 2023
On June 14, 2023,Vetter, one of the world's leading Contract Development and Manufacturing Organizations, is consistently pursuing improvements to its sustainability strategy.
High Demand: Vetter Expands Production Capacities and Services Offered at Its Austrian Site PharmaSources
May 10, 2023
Vetter has completed the first year of production in Rankweil successfully and is preparing to further increase production capacities and capabilities on site.
Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market PharmaSources
February 02, 2023
Both the US Skokie and European Rankweil sites address customer needs in early-phase drug development
Chinese CDMO Asymchem Expands US Footprint contractpharma
February 11, 2022
Acquires Snapdragon Chemistry for $58 million.
TriRx Completes Acquisition of Elanco Manufacturing Facility contractpharma
February 09, 2022
The Speke, UK facility offers capabilities to manufacture human health and animal health products.
Olon Expands High Containment API Operations contractpharma
February 09, 2022
The CDMO plans to invest €27 million over the next two years including a newly commissioned production line.
MilliporeSigma Reorganizes and Adopts New Operating Model contractpharma
February 09, 2022
Aims to support the long-term growth strategy of the Life Science business sector.
Rentschler Biopharma Strengthens Leadership Team contractpharma
February 04, 2022
Hires executives with strong experience in strategy, operations and project management.
Recipharm Secures Vaccine Manufacturing Deal contractpharma
January 28, 2022
Inks deal with top 10 big pharma and will provide manufacturing support from facility in Kaysersberg, France.
Alcami Expands Biologics Footprint with Investment in Durham contractpharma
January 28, 2022
$10 million investment doubles laboratory footprint and enhances large molecule and cell and gene therapy analytical service offering.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page